The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents
Background: The optimal duration of clopidogrel use for prevention of stent thrombosis with drug-eluting stent (DES) use is uncertain. Our objective was to determine whether the planned duration of clopidogrel at the time of percutaneous coronary intervention affected patient outcomes. Methods: We a...
| Main Authors: | Butler, M., Eccleston, D., Clark, D., Ajani, A., Andrianopoulos, N., Brennan, A., New, G., Black, A., Szto, G., Reid, Christopher, Yan, B., Shaw, J., Dart, A., Duffy, S. |
|---|---|
| Format: | Journal Article |
| Published: |
Mosby, INC
2009
|
| Online Access: | http://hdl.handle.net/20.500.11937/18570 |
Similar Items
Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents
by: Shaw, J., et al.
Published: (2008)
by: Shaw, J., et al.
Published: (2008)
Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction
by: Gurvitch, R., et al.
Published: (2010)
by: Gurvitch, R., et al.
Published: (2010)
Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents
by: Freeman, M., et al.
Published: (2009)
by: Freeman, M., et al.
Published: (2009)
Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents
by: Wilson, W., et al.
Published: (2011)
by: Wilson, W., et al.
Published: (2011)
Rates of Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents (from a Large Australian Multicenter Registry)
by: Yan, B., et al.
Published: (2008)
by: Yan, B., et al.
Published: (2008)
Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry
by: Yan, B., et al.
Published: (2008)
by: Yan, B., et al.
Published: (2008)
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)
by: Chan, W., et al.
Published: (2012)
Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.
by: Yudi, M., et al.
Published: (2016)
by: Yudi, M., et al.
Published: (2016)
A PRACTICAL DEFINITION OF LATE STENT THROMBOSIS: INSIGHTS FROM THE MELBOURNE INTERVENTIONAL GROUP REGISTRY
by: Yan, B., et al.
Published: (2011)
by: Yan, B., et al.
Published: (2011)
Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
by: Mohd Shah, Azarisman Shah, et al.
Published: (2011)
by: Mohd Shah, Azarisman Shah, et al.
Published: (2011)
Progress Towards a National Cardiac Procedure Database-Development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) Registries
by: Chan, W., et al.
Published: (2011)
by: Chan, W., et al.
Published: (2011)
IMPACT OF STENT DIAMETER ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH 2ND GENERATION DRUG ELUTING STENTS: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY
by: Plitt, A., et al.
Published: (2018)
by: Plitt, A., et al.
Published: (2018)
Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary intervention
by: Lim, H., et al.
Published: (2013)
by: Lim, H., et al.
Published: (2013)
A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era
by: Ariyaratne, T., et al.
Published: (2016)
by: Ariyaratne, T., et al.
Published: (2016)
Are intra-aortic balloon pumps harmful in cardiogenic shock?
by: Stub, D., et al.
Published: (2011)
by: Stub, D., et al.
Published: (2011)
Are intra-aortic balloon pumps harmful in cardiogenic shock?
by: Stub, D., et al.
Published: (2011)
by: Stub, D., et al.
Published: (2011)
Short- and long-term outcomes of out-of-hospital cardiac arrest following ST-elevation myocardial infarction managed with percutaneous coronary intervention
by: Dawson, L.P., et al.
Published: (2020)
by: Dawson, L.P., et al.
Published: (2020)
PROLONGED EFFECTIVENESS OF CORONARY ARTERY BYPASS SURGERY VERSUS DRUG-ELUTING STENTS IN DIABETICS WITH MULTI-VESSEL DISEASE: AN UPDATED META-ANALYSIS
by: Ariyaratne, T., et al.
Published: (2012)
by: Ariyaratne, T., et al.
Published: (2012)
The Establishment of the Victorian Cardiac Outcomes Registry (VCOR): Monitoring and Optimising Outcomes for Cardiac Patients in Victoria
by: Stub, D., et al.
Published: (2017)
by: Stub, D., et al.
Published: (2017)
TCT-250 Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry.
by: Papapostolou, S., et al.
Published: (2016)
by: Papapostolou, S., et al.
Published: (2016)
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)
by: Chan, W., et al.
Published: (2012)
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
by: Bath, Philip M.W., et al.
Published: (2018)
by: Bath, Philip M.W., et al.
Published: (2018)
Incidence, Predictors and Clinical Outcomes of Stent Thrombosis Following Percutaneous Coronary Intervention in Contemporary Practice
by: Batchelor, R., et al.
Published: (2020)
by: Batchelor, R., et al.
Published: (2020)
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
by: Sacco, Ralph L., et al.
Published: (2008)
by: Sacco, Ralph L., et al.
Published: (2008)
The prevalence of co-administration of clopidogrel and proton pump inhibitors
by: Shrestha, Kajal, et al.
Published: (2011)
by: Shrestha, Kajal, et al.
Published: (2011)
Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Batchelor, R.J., et al.
Published: (2022)
by: Batchelor, R.J., et al.
Published: (2022)
Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: An updated systematic review and meta-analysis
by: Ariyaratne, T., et al.
Published: (2014)
by: Ariyaratne, T., et al.
Published: (2014)
Cardiovascular medication use following percutaneous coronary intervention: The Australian experience
by: Cole, J., et al.
Published: (2014)
by: Cole, J., et al.
Published: (2014)
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Amin, Arwa M., et al.
Published: (2017)
by: Amin, Arwa M., et al.
Published: (2017)
Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in Australia
by: Wlodarczyk, J., et al.
Published: (2015)
by: Wlodarczyk, J., et al.
Published: (2015)
Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries
by: Yan, B., et al.
Published: (2009)
by: Yan, B., et al.
Published: (2009)
Heart Rate as a Predictor of Outcome Following Percutaneous Coronary Intervention
by: O'Brien, J., et al.
Published: (2018)
by: O'Brien, J., et al.
Published: (2018)
Pretreatment with Dual Antiplatelet Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention
by: Yudi, M., et al.
Published: (2015)
by: Yudi, M., et al.
Published: (2015)
Prediction Of Uncontrolled Dyslipidemia
Of Cardiac Outpatients And The Adverse
Effect Of Pharmaceutical Excipients
by: Abdulrazzaq, Hadeer Akram
Published: (2013)
by: Abdulrazzaq, Hadeer Akram
Published: (2013)
Recent trends in Australian percutaneous coronary intervention practice: Insights from the melbourne interventional group registry
by: Yan, B., et al.
Published: (2011)
by: Yan, B., et al.
Published: (2011)
Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)
by: Yeoh, J., et al.
Published: (2017)
by: Yeoh, J., et al.
Published: (2017)
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: Data from a large multi-centre Australian registry
by: Ariyaratne, T., et al.
Published: (2013)
by: Ariyaratne, T., et al.
Published: (2013)
Role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI)
by: Freeman, M., et al.
Published: (2015)
by: Freeman, M., et al.
Published: (2015)
Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromes
by: Yudi, M., et al.
Published: (2016)
by: Yudi, M., et al.
Published: (2016)
Factors affecting the elution of Pt, Pd and Au cyanide from activated carbon
by: Snyders, C., et al.
Published: (2015)
by: Snyders, C., et al.
Published: (2015)
Similar Items
-
Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents
by: Shaw, J., et al.
Published: (2008) -
Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction
by: Gurvitch, R., et al.
Published: (2010) -
Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents
by: Freeman, M., et al.
Published: (2009) -
Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents
by: Wilson, W., et al.
Published: (2011) -
Rates of Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents (from a Large Australian Multicenter Registry)
by: Yan, B., et al.
Published: (2008)